![](/img/cover-not-exists.png)
157PPrognostic impact of the use of antibiotics in patients with advanced non-small cell lung cancer (NSCLC) receiving PD-(L)1 targeting monoclonal antibodies
Schett, A, Rothschild, S I, Mauti, L A, Schmid, S, Appenzeller, C, Curioni-Fontecedro, A, Frueh, M, Joerger, MVolume:
30
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz063.055
Date:
April, 2019
File:
PDF, 79 KB
english, 2019